• DOI:10.4172/2161-069X.1000268
Corpus ID: 57556734

Case Series Investigating the Clinical Practice Experience of Serum-Derived Bovine Immunoglobulin/Protein Isolate (SBI) in the Clinical Management of Patients with Inflammatory Bowel Disease

@article{Good2015CaseSI,
  title={Case Series Investigating the Clinical Practice Experience of Serum-Derived Bovine Immunoglobulin/Protein Isolate (SBI) in the Clinical Management of Patients with Inflammatory Bowel Disease},
  author={L. Good and R. Panas},
  journal={Journal of Gastrointestinal and Digestive System},
  year={2015},
  volume={2015}
}

• L. Good, R. Panas
• Published 2015
• Medicine
• Journal of Gastrointestinal and Digestive System

Background: Serum-derived bovine immunoglobulin/protein isolate (SBI), a specially formulated oral protein source of >50% IgG and ~60% total immunoglobulins, has a multifaceted mechanism of action binding microbial components, maintaining gastrointestinal immune balance, managing gut barrier function and improving nutrient utilization. IBD animal models and a human refractory case study demonstrated that SBI can attenuate both inflammatory biomarkers and histological parameters in the bowel… Expand

View via Publisher

doi.org

Save to Library

Create Alert

Cite

Launch Research Feed